Top Markets
Coin of the day
Idogen AB (publ) Idogen AB (publ)

Idogen AB (publ)

IDOGEN
Clasificación en acciones #37811
Idogen AB (publ) is a Swedish biotechnology company specializing in the... Idogen AB (publ) is a Swedish biotechnology company specializing in the development of tolerogenic cell therapies. These innovative treatments are engineered to prevent a patient's immune system from attacking crucial elements, including biological agents, transplanted organs, and the body's own cells or tissues. The company's most advanced product in development is IDO 8, designed for individuals with severe haemophilia A who have developed neutralizing antibodies against their vital coagulation factor VIII treatment. Idogen is also developing IDO T, a tolerogenic cell therapy intended to prevent organ transplant rejection, primarily for kidney transplants, and IDO AID, aimed at treating autoimmune diseases. Established in 2008, the company is headquartered in Lund, Sweden.
Precio por acción
$0.01345907
Última sincronización: 2024-07-12
Capitalización bursátil
$1.43M
Cambio (1 día)
22.16%
Cambio (1 año)
0.00%
País
SE
Comercio Idogen AB (publ) (IDOGEN)

Categoría

Historial del precio de la acción de Idogen AB (publ) (IDOGEN)
Precio más alto de cierre: $0.01 el 2024-07-01

Precio más bajo de cierre: $6.87 el 2015-06-01
Historial del precio de la acción de Idogen AB (publ) desde 2015 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 17.75%
2023 -33.56%
2022 -90.58%
2021 -53.76%
2020 -45.68%
2019 -53.15%
2018 -66.56%
2017 -52.66%
2016 54.52%
2015 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE